Dr. Daniel Warren of Envita Medical Centers Demystifies Lyme Disease on Hiking Radio Network Podcast

Dr. Daniel Warren of Envita Medical Centers Demystifies Lyme Disease on Hiking Radio Network Podcast

The gradual increase in tick population has alerted Americans, especially hikers, who want to know more about the tick-borne infection, Lyme disease, and kind of treatments required to recover from it. “It's important to differentiate the time frame in which there has been [tick] exposure,” said Dr. Daniel Warren, N.M.D., Envita Medical Centers, a Center of Excellence in Lyme disease treatment.

Speaking to the host Steve Adams, Dr. Warren explained that if Lyme disease is diagnosed after initial exposure, which is within the first 2 to 4 weeks of being bit by a tick, then the standard course of oral antibiotic treatment may be enough to treat it. However, the challenge lies in the fact that most people are not aware because they may not manifest the standard symptom of a bulls-eye rash on the tick-bite site. Later when they experience other physiological and neurological symptoms of Lyme disease, they are unable to correlate those symptoms to Lyme disease because they had not noticed the tick-bite in the first place.

“People can get this infection and not manifest the disease for years or decades,” said Dr. Warren. He highlighted how his team at Envita has successfully treated many Lyme disease patients who were bitten in their childhood, but did not manifest symptoms till later in life, when their immune system had been compromised. Explaining the role of the immune system in Lyme disease, Dr. Warren said, “Part of the challenge with Lyme disease is that it degrades the immune system.”

To overcome these challenges of Lyme disease, the specially trained team at Envita Medical Centers utilizes the personalized precision medicine approach for not just targeting the Lyme-causing bacteria, but also reactivating the immune system for lasting results.

To know more about Lyme disease, its associated infections, and connection to cancer, listen to this podcast.